Abstract
Dipankar Pal1*, Manoj Kumar Gupta1, Tamalika Das1 and Shristi Butta2 1School of Tropical Medicine, 108, Chittaranjan Avenue, Kolkata-700073, West Bengal, India 2Department of Pathology, NRS Medical College, 138 AJC Bose Road, Kolkata-700014, West Bengal, India *Corresponding author: Dipankar Pal, RMO cum Clinical Tutor, Department of Tropical Medicine, School of Tropical Medicine, 108, Chittaranjan Avenue, Kolkata-700073, West Bengal, India, Tel: +91-9432113713; E-mail: dipankarpal.2009@gmail.com
Highlights
Post kala-azar dermal leishmaniasis (PKDL) is a complication of visceral leishmaniasis (VL). It is characterised by macular, maculopapular and/or nodular lesions in a patient who has recovered from VL
It is commoner in Sudan where it follows as much as 50% of treated VL cases, whereas the figure is only 5-10% in India. [1]
PKDL probably has an important role in interepidemic periods of VL in maintaining the parasite reservoir [1]
Summary
Post kala-azar dermal leishmaniasis (PKDL) is a complication of visceral leishmaniasis (VL). It is characterised by macular, maculopapular and/or nodular lesions in a patient who has recovered from VL. It is commoner in Sudan where it follows as much as 50% of treated VL cases, whereas the figure is only 5-10% in India. PKDL probably has an important role in interepidemic periods of VL in maintaining the parasite reservoir [1]. PCR and monoclonal antibodies may detect parasites in more than 80% of cases [2]. Treatment is required only in severe and chronic cases in Sudan
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have